Torben Sand - Scandinavian Tobacco Head Relations
| 0RES Stock | 96.80 0.30 0.31% |
Executive
Torben Sand is Head Relations of Scandinavian Tobacco Group
| Address | Sandtoften 9, Gentofte, Denmark, 2820 |
| Phone | 45 39 55 62 00 |
| Web | https://www.st-group.com |
Scandinavian Tobacco Management Efficiency
The company has return on total asset (ROA) of 0.0611 % which means that it generated a profit of $0.0611 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1164 %, meaning that it generated $0.1164 on every $100 dollars invested by stockholders. Scandinavian Tobacco's management efficiency ratios could be used to measure how well Scandinavian Tobacco manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Scandinavian Tobacco's Other Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 131 M in 2024, whereas Total Assets are likely to drop slightly above 15.1 B in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| William Valle | Fresenius Medical Care | 64 | |
| Shlomo BenNaim | MTI Wireless Edge | N/A | |
| Michael King | Advanced Medical Solutions | N/A | |
| Elhanan Zeira | MTI Wireless Edge | N/A | |
| Martin Hudson | The Mercantile Investment | N/A | |
| Claudia Thom | CompuGroup Medical AG | 53 | |
| Angela Teufer | CompuGroup Medical AG | 51 | |
| Michael Franz | CompuGroup Medical AG | N/A | |
| Helge Wei | CompuGroup Medical AG | N/A | |
| Oliver Maier | Fresenius Medical Care | N/A | |
| Owen Bromley | Advanced Medical Solutions | N/A | |
| Carl Ackerley | Taylor Maritime Investments | N/A | |
| Jan Sweetnam | Federal Realty Investment | 64 | |
| Daniela Hommel | CompuGroup Medical AG | 49 | |
| Glenn Slater | Fresenius Medical Care | N/A | |
| Ross McDonald | Advanced Medical Solutions | N/A | |
| Emanuele Mugnani | CompuGroup Medical AG | 54 | |
| Oliver Bruzek | CompuGroup Medical AG | N/A | |
| Alan Richardson | Advanced Medical Solutions | N/A | |
| Dominik Heger | Fresenius Medical Care | N/A | |
| Stefanie Peters | CompuGroup Medical AG | 55 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0611 |
Scandinavian Tobacco Leadership Team
Elected by the shareholders, the Scandinavian Tobacco's board of directors comprises two types of representatives: Scandinavian Tobacco inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scandinavian. The board's role is to monitor Scandinavian Tobacco's management team and ensure that shareholders' interests are well served. Scandinavian Tobacco's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scandinavian Tobacco's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Niels Frederiksen, President CEO | ||
| Simon Augustesen, Director Communications | ||
| Hanne Berg, Chief VP | ||
| Oliver Hass, Managing Germany | ||
| Marianne Bock, Executive CFO | ||
| Jakob Berning, Senior Tax | ||
| Morten Guldager, Senior Partnering | ||
| Torben Sand, Head Relations | ||
| Christian Srensen, Ex Marketing | ||
| Lars Wassberg, Senior Marketing | ||
| Dorte Morell, Sr AS | ||
| Mette Valentin, Senior Affairs | ||
| Thomas Lindegaard, Senior Affairs |
Scandinavian Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scandinavian Tobacco a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0611 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 13.62 B | |||
| Shares Owned By Insiders | 13.32 % | |||
| Shares Owned By Institutions | 59.39 % | |||
| Revenue | 8.86 B | |||
| Gross Profit | 4.31 B | |||
| EBITDA | 1.9 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Scandinavian Stock Analysis
When running Scandinavian Tobacco's price analysis, check to measure Scandinavian Tobacco's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandinavian Tobacco is operating at the current time. Most of Scandinavian Tobacco's value examination focuses on studying past and present price action to predict the probability of Scandinavian Tobacco's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandinavian Tobacco's price. Additionally, you may evaluate how the addition of Scandinavian Tobacco to your portfolios can decrease your overall portfolio volatility.